Prezatide copper acetate

Drug Profile

Prezatide copper acetate

Alternative Names: GHK-Cu; GraftCyte; Iamin; Iamin-1B; Iamin® gel; KPC 1193; Neova; PC 1020

Latest Information Update: 12 Nov 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ProCyte Corporation
  • Class Antihyperglycaemics
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Burns; Chronic wounds; Skin ulcer
  • Discontinued Diabetic foot ulcer; Inflammatory bowel diseases; Ulcerative colitis; Wounds

Most Recent Events

  • 12 Nov 2008 Typo fixed
  • 12 May 2005 ProCyte Corporation has been acquired by PhotoMedex
  • 18 Nov 2003 Discontinued - Phase-II for Inflammatory bowel disease in USA (Rectal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top